Jetide Health
Wuhan Jetide Biotech Co., Ltd. is an influential company in the field of small molecule peptides. Since its establishment in September 2012 in Wuhan, Hubei Province, China, the company has consistently focused on the research, production, and sales of small molecule peptides. With outstanding technical capabilities and market insights, it has gradually built a strong reputation within the industry.
Our company own 200 acres of chemical land and a self-built factory covering 20,000 square meters, providing ample physical space for large-scale production and research and development. Currently, the company has four industrial production lines with an annual capacity of up to 1,000 tons of small molecule peptides, ensuring robust production capabilities to meet market demand.
In terms of research and development, Wuhan Jetide Biotech Co., Ltd. boasts a professional team of over 30 researchers with more than 10 years of experience in small molecule peptide synthesis and development. This team has accumulated expertise in synthesis, purification, and analytical techniques related to small molecule peptides, enabling them to undertake customized synthesis and industrial-scale amplification, providing personalized solutions for clients.
Furthermore, we strictly adhere to Good Manufacturing Practice (GMP) standards, covering everything from raw material procurement and production process control to product quality testing, sales, and after-sales service. This commitment ensures both product quality and safety, meeting various audit requirements from domestic and international clients and earning widespread trust and cooperation opportunities.
Looking ahead, Wuhan Jetide Biotech Co., Ltd. will continue to deepen its expertise in the small molecule peptide field, enhance technological innovation capabilities, expand production scale, improve product quality, and increase production efficiency. Additionally, the company will actively explore domestic and international markets, seeking more partners and business opportunities to contribute further to the development of the biotechnology industry